Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - a Prospective Double-masked Cross-over Study

NCT04423341 is registered in ClinicalTrials.gov with Silkiss Eye Surgery as lead sponsor.

NCT NCT04423341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04423341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - a Prospective Double-masked Cross-over Study
Lead sponsor
Silkiss Eye Surgery
Phase
Phase 2/3
Overall status
Completed
Start date
May 20, 2020
Completion date
October 1, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blepharospasm, blepharospasm, benign essential, cbd